Literature DB >> 6797699

Bone turnover in Paget's disease: biochemical and kinetic measurements during salmon calcitonin therapy.

D J Hosking, W Vennart, L B Huddlestone.   

Abstract

A comparison of calcium-47 kinetics and biochemical measurements has been made in 25 previously untreated patients with Paget's disease. The rate of disappearance of 47Ca into bone with a turnover time of more than 5 days was measured as A5, and the pool size with a turnover time of less than 5 days as E5. In moderately active disease the reductions in A5 and E5 to be anticipated from treatment seem to be offset by an increase in exchangeability due to remineralization of osteoid. In more active disease the effect of calcitonin may be to shift bone formation from a woven to a lamellar pattern as well as to reduce turnover. Under these circumstances both A5 and E5 are reduced by treatment more in keeping with biochemical changes.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6797699     DOI: 10.1007/BF02409476

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  23 in total

Review 1.  PAGET'S DISEASE OF BONE: CLINICAL AND METABOLIC OBSERVATIONS.

Authors:  C N DE DEUXCHAISNES; S M KRANE
Journal:  Medicine (Baltimore)       Date:  1964-05       Impact factor: 1.889

2.  [Method for the measurement of the principal routes of calcium metabolism in man].

Authors:  J P AUBERT; G MILHAUD
Journal:  Biochim Biophys Acta       Date:  1960-03-25

3.  Radiocalcium studies of bone formation rate in human metabolic bone disease.

Authors:  R P HEANEY; G D WHEDON
Journal:  J Clin Endocrinol Metab       Date:  1958-11       Impact factor: 5.958

4.  Kinetics of strontium metabolism in man.

Authors:  G C BAUER; R D RAY
Journal:  J Bone Joint Surg Am       Date:  1958-01       Impact factor: 5.284

5.  Skeletal renewal and metabolic bone disease.

Authors:  W H Harris; R P Heaney
Journal:  N Engl J Med       Date:  1969-01-23       Impact factor: 91.245

6.  Metabolic effects of synthetic salmon calcitonin in Paget's disease of bone.

Authors:  A Avramides; R K Baker; S Wallach
Journal:  Metabolism       Date:  1974-11       Impact factor: 8.694

7.  Effects of synthetic salmon calcitonin in patients with Paget's disease of bone.

Authors:  C R Hamilton
Journal:  Am J Med       Date:  1974-03       Impact factor: 4.965

8.  Histologic changes in Paget's disease treated with calcitonin.

Authors:  V L Fornasier; K Stapleton; C C Williams
Journal:  Hum Pathol       Date:  1978-07       Impact factor: 3.466

9.  Collagen-like fragments: excretion in urine of patients with Paget's disease of bone.

Authors:  S M Krane; A J Muñoz; E D Harris
Journal:  Science       Date:  1967-08-11       Impact factor: 47.728

10.  Long-term treatment of Paget's disease of bone with salmon calcitonin.

Authors:  W C Sturtridge; J E Harrison; D R Wilson
Journal:  Can Med Assoc J       Date:  1977-11-05       Impact factor: 8.262

View more
  1 in total

1.  Paget's disease of bone. An update on management.

Authors:  D J Hosking
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.